The effect of low-dose recombinant human erythropoietin therapy on a quality of life in hemodialysis patients with end-stage renal disease and anemia;WPLYW MALYCH DAWEK LUDZKIEJ REKOMBINOWANEJ ERYTHROPOETYNY NA JAKOSC ZYCIA CHORYCH Z NIEDOKRWISTOSCIA W PRZEBIEGU SCHYLKOWEJ NIEWYDOLNOSCI NEREK LECZONYCH DIALIZAMI POZAUSTROJOWYMI

Polskie Archiwum Medycyny Wewnetrznej

Volumn 96, Issue 2, 1996, Pages 143-152

  Matuszkiewicz Rowińska, Joanna ^a,e   Marusza, Wojciech ^a   Andrzejewski, Andrzej ^b   Goliat, Elzbieta ^a   Pacocha, Ewa ^a   Świtalski, Marek ^c   Zawadzka, Maria ^d   Ostrowski, Kazimierz ^a  

^a Klin Chorob Wewnetrznych/R W   (Poland)

^b Laboratorium Centralne CSK I   (Poland)

^c Oddzial Nefrologii SW   (Poland)

^d INSTITUTE OF CARDIOLOGY   (Poland)

^e Samodzielny Publiczny Centralny S   (Poland)

Author keywords

Anemia; End stage renal failure; Erythropoietin; Hemodialysis; Quality of life; Sex hormones

Indexed keywords

PROLACTIN; RECOMBINANT ERYTHROPOIETIN; SEX HORMONE; ERYTHROPOIETIN; HEMOGLOBIN; HORMONE;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; QUALITY OF LIFE; SEXUAL FUNCTION; SUBCUTANEOUS DRUG ADMINISTRATION; ADOLESCENT; BLOOD; CHRONIC KIDNEY FAILURE; FITNESS; HEMATOCRIT; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SEXUAL BEHAVIOR; THERMOREGULATION;

ADOLESCENT; ADULT; ANEMIA; BODY TEMPERATURE REGULATION; ERYTHROPOIETIN; FEMALE; HEMATOCRIT; HEMOGLOBINS; HORMONES; HUMANS; INJECTIONS, SUBCUTANEOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYSICAL FITNESS; QUALITY OF LIFE; RENAL DIALYSIS; SEXUAL BEHAVIOR;

EID: 0029969758     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Eschbach J.W.: The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Nephrology Forum. Kidney Int., 1989, 35, 134.
2. Kokot F., Wiȩcek A.. Grzeszcak W., Klin M:. Influence of erythropoietin treatment on folliotropin and lutropin response to luliberin and plasma testosterone levels in haemodialyzed patients. Nephron, 1990, 56, 126.
3. Lin F.K., Suggs S., Lin Ch.: Cloning and expression of the human erythropoietin gene. Proc. Nat. Acad. Sci. USA, 1985, 92, 7580.
4. Powell J.S., Benker K.L., Lebo R.W., Adamson J.W.: Human erythropoietin gene: High level expression in stably transfected mammalian cells and chromosome localization. Proc. Nat. Acad. Sci. USA 1986, 83, 6465.
5. Eschbach J.W., Egrie J., Downing M., Browne J , Admason J.: Correction of anemia of end-stage renal disease with recombinant human erythropoietin. N. Engl. J. Med.. 1987, 316, 73.
6. Temple R.M., Langan S.J., Deary I.J., Winney R.J.: Recombinant erythropoietin improves cognitive function in chronic haemodialysis patients. Nephrol. Dial. Transplant., 1992, 7, 240.
7. Wizemann V., Kaufmann J., Kramer W.: Effects of erythropoietin in ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease. Nephron, 1992, 62, 161.
8. Backer A., Reimers E., Nonnast-Daniel B i wsp.: Effect of erythropoietin treatment on hemoglobin O2 - affinity and physical performance in patients with renal anemia. Kidney Int., 1988, 33, 217.
9. McMahon L.P., Dawborn J.K.: Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin. Am. J. Nephrol., 1992, 12, 162.
10. Maj S.: Badanie krwinek czerwonych i hemoglobiny. W. Pawlski S: Diagnostyka laboratoryjna w hematologii PZWL, Warszawa, 1977.
11. Casati S., Passerini P., Campise i wsp. Benefit and risks of protracted treatment with human recombinant erythropoetin in patients having haemodialysis Br. Med. J., 1987, 4, 1017.
12. Valderrabano F., Moreno F., Aracil F.J.: A cotrolled study on the effect of life of elderly haemodialysis patients. J. Am. Soc. Nephrol., 1992, 3, 432.
13. Fifteenth Report of the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), wyd. przez Disney A.P.S. Australia, 1992.
14. Suzuki M., Hirasawa Y., Hirashima K.: Dose-finding, double blind, clinical trial of human recombinant erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Contrib. Nephrol., 1989, 76, 179.
15. Kokot F., Wiȩcek A., Grzeszezak W., Klepacka J., Klin M., Lao M . Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients. Contrib. Nephrol., 1989, 76, 257
16. Haley N.R., Matsumoto A.M., Eschbach J.W., Adamson J.W.: Low testosterone levels increase in male hemodialysis patients treated with recombinant human erythropoietin. Abstracts of 21st Meeting of the American Society of Nephrology. San Antonio USA. 1988.
17. Odger R.S.C., Sheldon W.L., Watson M.J.: Zinc defficiency and hyperprolactinaemia are not reversible causes of sexual dysfunction in uremia. Nephrol. Dial. Transplant., 1989, 4, 888.
18. Odone P., Ortensia A., Iberti M., della Volpe M.: Subthalamic - pituary - gonadal axis after two years of rHuEpo treatment. Nephrol. Dial. Transplant., 1994, 9, 1035.
19. Schaefer R.M., Kokot F., Kuiner B., Zech M., Heidland A.: Normalization of elevated prolactin levels in hemodialysis patients on erythropoietin. Nephron. 1988, 50, 400.
20. Bommer J., Kugel M., Schwobel B. i wsp.: Improved sexual function during recombinant human erythropoietin therapy. Nephrol. Dial. Transplant., 1990, 5, 204.
21. Schaefer F.: Recombinant human erythropoietin treatment increases central activity of the gonadotropic hormone axis in patients with end-stage renal failure. W; Proceedings of European Erythropoietin Symposium. Sewilla, 1994, str. 31.
22. Sundal E., Businger J., Kappeler A.: Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. Nephrol Dial. Transplant., 1991, 6, 955.
23. Fernandez A., Vega N., Jimenez F. i wsp : Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am. J. Nephrol., 1991, 12, 207.
24. Koomans H.A.: Epidemiology of erythropoietin - associated hypertension. W: Proceedings of European Erythropoietin Symposium. Sewilla, 1994, str. 59.
25. Tagawa N., Nagano F., Saito H : Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin. Proposal for thee haematocrit most beneficial to hemodynamics. Clin. Nephrol., 1991, 35, 35.